UPDATE 1-Shanghai Junshi Biosciences soars 21 percent on HK debut

HONG KONG, Dec 24 (Reuters) – Chinese biotech startup Shanghai Junshi Biosciences Co Ltd soared more than 21 percent in its Hong Kong debut on Monday after raising $394 million in its IPO, a rare stro…
( read original story …)


Related Post